Merck to Acquire Acceleron Pharma Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Tesla acquires AI hardware company for up to $2 billion in stock
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $11.5 Billion, Deal Brings in Potential Blockbuster in PAH Says Analyst
September 30, 2021 7:56 AM EDTMerck (NYSE: MRK) announced today that it has agreed to acquire Acceleron Pharma (Nasdaq: XLRN) for $180 per share in cash in the deal valued at $11.5 billion.
Todays announcement has confirmed media reports that XLRN is in advanced talks with MRK over a takeover deal.
Strategic business development is a top... More
